Financials in USD. Standardized financial statements.
A compact view of how China Medical System Holdings Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $8.00B | $7.47B | $8.01B | $9.15B | $8.34B | $6.95B | $6.07B | $5.43B | $5.35B | $4.90B |
| Revenue Growth? | +7.1% | -6.8% | -12.4% | +9.8% | +20.0% | +14.4% | +11.8% | +1.6% | +9.1% | 0.0% |
| Cost of Revenue? | $2.28B | $2.05B | $1.94B | $2.11B | $2.09B | $1.81B | $1.53B | $1.52B | $1.87B | $1.99B |
| Gross Profit? | $5.72B | $5.42B | $6.08B | $7.04B | $6.25B | $5.13B | $4.55B | $3.92B | $3.48B | $2.91B |
| Gross Margin? | +71.5% | +72.6% | +75.8% | +76.9% | +74.9% | +73.9% | +74.9% | +72.1% | +65.0% | +59.4% |
| Operating Expenses? | $4.18B | $3.69B | $3.36B | $3.39B | $3.03B | $2.32B | $2.14B | $1.90B | $1.58B | $1.37B |
| Operating Income? | $1.54B | $1.73B | $2.71B | $3.55B | $3.15B | $2.76B | $2.64B | $2.28B | $2.25B | $1.69B |
| EBITDA? | $1.80B | $2.31B | $2.92B | $3.76B | $3.70B | $3.05B | $2.75B | $2.20B | $2.09B | $1.69B |
| Income Before Tax | $2.05B | $2.01B | $2.87B | $3.76B | $3.46B | $2.82B | $2.49B | $2.01B | $1.81B | $1.50B |
| Income Tax Expense | $642.76M | $397.23M | $489.34M | $486.65M | $431.32M | $260.39M | $532.00M | $161.78M | $138.49M | $122.52M |
| Net Income? | $1.45B | $1.62B | $2.40B | $3.26B | $3.02B | $2.53B | $1.96B | $1.85B | $1.67B | $1.38B |
| EPS? | $0.60 | $0.67 | $0.98 | $1.33 | $1.22 | $1.02 | $0.79 | $0.74 | $0.67 | $0.55 |
| Diluted EPS? | $0.60 | $0.67 | $0.98 | $1.33 | $1.22 | $1.02 | $0.79 | $0.74 | $0.67 | $0.55 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality